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Abstract
AIM: To determine the prevalence of antralization at the
edge of proximal gastric ulcers, and the effect of H. pylori
eradication on the mucosal appearances.
METHODS: Biopsies were taken from the antrum, body
and the ulcer edge of patients with benign proximal gastric
ulcers before and one year after treatment. Gastric mucosa
was classified as antral, transitional or body type. H. pylori
positive patients received either triple therapy, or omeprazole.
RESULTS: Patients with index ulcers in the incisura, body
or fundus (n=116) were analyzed. Antral-type mucosa was
more prevalent at the ulcer edge in H. pylori-positive patients
than H. pylori-negative patients (93 % vs 60 %, OR=8.95,
95 %CI: 2.47-32.4, P=0.001). At one year, there was a
significant reduction in the prevalence of antralization (from
93 % to 61 %, P=0.004) at the ulcer edge in patients with
H. pylori being eradicated. However, there was no difference
in the prevalence of antralization at the ulcer edge in those
with persistent infection.
CONCLUSION: H. pylori infection is associated with
antralization at the edge of proximal gastric ulcers, which
may be reversible in some patients after eradication of the
infection.
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INTRODUCTION
Peptic ulcer disease is common, and is associated with
considerable mortality due to complications such as bleeding
and perforation[1]. H. pylori infection is now recognized to be
a major cause for peptic ulcer, accounting for up to 90 % of
duodenal ulcer cases and 80 % of gastric ulcer cases, with the
use of non-steroidal anti-inflammatory drugs being another
major cause[2-4]. While gastric metaplasia in duodenum has been
identified to be an important morphopathological change in
the development of H. pylori-associated duodenal and
prepyloric ulcer[5-7], the mucosal morpho-pathogenesis of
gastric ulcer, which occurs predominantly along the body-
antrum transitional zone (particularly at the gastric incisura),
remains unclear. Previous studies have observed a stem-cell-
derived “ulcer-associated cell lineage” (UACL) at the sites of
chronic gastrointestinal ulceration, commonly found in the
borders of Crohn’s ulcers in small bowel, and in gastroduodenal
ulceration[8-11]. In the literature, UACL was usually described
as pseudopyloric (or pyloric) metaplasia, because it has
morphological similarities to pyloric glands[8, 9], and similar
changes can occur in other tissues, such as gall bladder, bile
ducts, and pancreatic ducts, often associated with malignant
transformation of these tissues[12-16]. In the stomach,
pseudopyloric metaplasia is specifically defined as a replacement
of specialized glands by mucous-secreting glands in the gastric
body or at the body-antrum junction[17], a concept identical to
“antralization” as described in our previous studies[18, 19].
      In a previous study, we have demonstrated that in the absence
of H. pylori infection, the gastric incisura mucosa belongs to
either body-type or transitional type in most (82 %) individuals,
suggesting that normal incisura mucosa is histologically distinct
from the antral mucosa, but more homologous to the body and
fundus mucosa[18]. However, H. pylori infection is associated
with the presence of antral (pyloric)-type mucosa in the
proximal stomach (i.e. gastric incisura, body and fundus),
indicating that H. pylori infection may be a causal factor for
antralization of the proximal stomach[18]. Thus, it is conceivable
that H. pylori-induced antralization may play an important
pathogenic role in proximal gastric ulceration, and eradication
of H. pylori infection may reverse antralization to normal
transitional or body type mucosa, and thus reduce the risk for
ulcer relapse. Therefore, the present study was carried out to
determine the prevalence of antralization at the edge of
proximal gastric ulcer in relation to H. pylori infection, and
the effect of H. pylori eradication on the mucosal appearances.
MATERIALS AND METHODS
Patients
One hundred and sixteen patients with newly diagnosed
uncomplicated benign-looking proximal gastric ulcers (>5 mm
in diameter and >1 mm in depth) at the Endoscopy Unit of
Department of Medicine, Queen Mary Hospital were included
in the study. The location of gastric ulcers and demographic
and clinical characteristics of these patients were summarized
in Table 1. Exclusion criteria at entry included patients who
had been taking aspirin or non-steroidal anti-inflammatory
drugs (NSAIDs) over the past year, or taking antibiotics, H2
receptor blockers, bismuth or proton pump inhibitors in the
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preceding 4 weeks, patients with previous gastric surgery, and
those with a histological diagnosis of gastric carcinoma or
lymphoma.
     Informed written consent was obtained from all patients
who participated in the trial. This project was approved by the
Ethics Committee of the University of Hong Kong.
Table 1  The demographic clinical characteristics of the pa-
tients initially recruited, according to the location of gastric
ulcers (n=116)
           Ulcer location
            Incisura (n=91)     Body (n=23)     Fundus (n=2)
Age (mean ±SD)    59.5±13.3    69.3±10.2   51.0±11.2
Gender (male/female)       60/31       17/6        2/0
Smoking (yes/no)       44/46       11/12        1/1
H.pylori status       81/10       19/4        1/1
(positive/negative)
Diagnosis of H. pylori infection
During the first endoscopy, three biopsies were taken at the
gastric antrum within 3 cm of the pylorus at the lesser curvature,
two at the midway between the pylorus and cardioesophageal
junction at the greater curvature, and four from the edge of
gastric ulcer. When the ulcer was present in the body, the body
biopsies were taken at least 3 cm apart from the ulcer. One
antral biopsy was used for a rapid urease test (RUT) and the
rest were sent for the detection of H. pylori infection and
histological examination after haematoxylin & eosin (H&E)
staining. All patients then received a 13C-urea breath test
following a standard protocol measured by an isotope ratio
mass spectrometer[20]. The definition of H. pylori infection in
this study required that at least two of the three tests (the RUT,
histology and 13C-urea breath test) were positive. The absence
of H. pylori infection required all three tests to be negative.
This definition was used as the “gold standard” in this study.
Histological examination
Slides were read by experienced pathologists who were blinded
to all clinical and endoscopic information, including the RUT
results. The mucosa of gastric biopsies taken from different
sites was classified as antral (mucous-secreting or pyloric) type,
body (acid-secreting or oxyntic) type or transitional (junctional)
type according to the definitions set out in the updated Sydney
system[21]. The characteristic feature of antral-type mucosa was
the presence of coiled and branching antral glands, which were
lined by mucus cells that were interspersed with endocrine
cells (chiefly G and D types), and a few parietal cells. The
glands in body-type mucosa were straight tubes that constituted
acid-producing parietal cells along with scattered mucus cells
in their upper portion and mainly chief cells in their lower portion,
with scattered argyrophilic endocrine cells. Transitional type
mucosa was a mixture of the architectural features and cell types
found in the antral and body type mucosae[21].
Treatment and endoscopy at one year
One hundred and one patients received triple therapy consisting
of clarithromycin 250 mg, metronidazole 300 mg each given
4 times daily for 2 weeks and sucralfate 1 gm 4 times daily for
4 weeks (n=54), or acid suppression therapy consisting of
omeprazole 20 mg daily for one year (n=47). Successful
eradication was indicated if the rapid urease test, histological
examination by H&E and Giemsa staining and 13C-urea breath
test were all negative at week 6 after treatment. 65 patients
(male/female 44/21, age (mean±SD) 61.9±11.0 years) received
either triple therapy (n=28), or omeprazole (n=37), with ulcers
completely healed at 12 weeks. Upper endoscopy and 13C-urea
breath test were repeated at month 12. Gastric biopsies were
obtained from the antrum, body and ulcer site (visible scar
area in 47 of 53 (90.6 %) cases with a healed ulcer) or the edge
of ulcer in 12 patients with relapsed ulcers, and assessed as
described above. Successful eradication was indicated if the
rapid urease test, histological examination by H&E and Giemsa
staining and 13C-urea breath test were all negative at week 6 or
month 12 after treatment. The histological characteristics of
these biopsies were compared with those biopsies taken at the
first endoscopy. Histological improvement of gastric mucosa
over the period of one year was defined as changes from antral
to transitional or body, or from transitional to body-type,
whereas worsening of gastric mucosa was defined as changes
from body to transitional or antral, or from transitional to
antral-type. An upper endoscopy and a 13C-urea breath test
were repeated at month 12 for 65 patients (male/female 44/
21, age (mean±SD) 61.9±11.0 years) who had their ulcers
completely healed 12 weeks after treatment. Gastric biopsies
were obtained from the antrum, body and ulcer site (visible
scar area) in 47 of 53 (90.6 %) cases with a healed ulcer or
the edge of ulcer in 12 patients with relapsed ulcers, and
assessed as described above. The histological characteristics
of these biopsies were compared with those biopsies taken at
the first endoscopy. Histological improvement of gastric
mucosa over the period of one year was defined as changes
from antral to transitional or body, or from transitional to
body-type, whereas worsening of gastric mucosa was defined
as changes from body to transitional or antral, or from
transitional to antral-type.
Statistical analysis
The Chi-squared test (with Yates’ correction if required), the
Fisher’s exact test or McNemar test was used for categorical
variables, and odds ratios (OR) and 95 % confidence interval
(CI) were estimated where appropriate. All tests were carried
out using the SPSS system (version 10.0, SPSS Inc. Chicago,
Illinois, USA). All P values calculated were two-tailed. The
alpha level of significance was set at P<0.05.
RESULTS
The presence of antral-type mucosa in the gastric body and
at the edge of proximal gastric ulcers
Of the 116 patients, 91 had the index ulcers at the incisura, 23
in the body and 2 in the fundus. Of these, 101 were H. pylori-
positive and 15 were H. pylori-negative. All biopsies taken
from the antrum showed antral-type mucosa. Overall, antral-
type mucosa was present in the gastric body in 6 (5.2 %)
patients and at the edge of proximal gastric ulcers in 103
(88.8 %) patients. Of H. pylori-positive patients 6 (5.9 %) had
antral-type mucosa and 4 (4 %) had transitional type mucosa
whereas all (100 %) of H. pylori-negative patients had body-
type mucosa at the gastric body. Antral-type mucosa was
present at the edge of proximal gastric ulcers in 93.1 % (94/
101) of H. pylori-positive patients and 60 % (9/15) of H. pylori-
negative patients (OR=8.95, 95 % CI: 2.47-32.4, c2=14.35,
P=0.001) (Figure 1). In H. pylori-positive patients, 81 had
ulcers at the incisura, 19 at the body and one at the fundus. In
the presence of H. pylori infection, there was no difference in
the prevalence of antral-type mucosa at the ulcer edge at
different gastric sites: 92.6 % (75/81) at the incisura, 94.7 %
(18/19) at the body and 100 % (1/1) at the fundus. In H. pylori-
negative patients, antral-type mucosa was present at the edges
of ulcers in 70 % (7/10), 50 % (2/4) and 0 % (0/1) of patients
when the ulcer occurred at the incisura, body and fundus,
respectively.
Changes of gastric mucosa in the gastric body and at the
edge of proximal gastric ulcers at one year
Of the 65 patients who were followed up for one year, 28 had
H. pylori infection eradicated and 27 had persistent infection.
Of the 12 patients with ulcers relapse, one (3.6 %) was from
patients in whom H. pylori infection was eradicated and 11
(29.7 %) were from those with persistent infection (OR=11.4,
95 % CI: 1.38-94.9, c2=5.61, P=0.018).
     There was a significant reduction in the prevalence of antral-
type mucosa at both the gastric body (from 7.1 % to 0 %) and
the gastric ulcer sites (from 92.9 % to 60.7 %, P=0.004,
McNemar test) in patients in whom H. pylori infection was
eradicated. However, there was no difference in the
prevalence of antral-type mucosa when H. pylori infection
was persistent (Figure 2).
Figure 1  Prevalence of antral-type mucosa at the edge of proxi-
mal gastric ulcers and non-ulcerated gastric body in H. pylori-
positive patients (H. pylori+, n=101) and those without H. py-
lori infection (H. pylori-, n=15).
  Kam-Chen
Figure 2  Presence of antral-type mucosa at the edge of proxi-
mal gastric ulcers and non-ulcerated gastric body in patients
with H. pylori eradicated (n=28) and in those with persistent
infection (n=37) before (month 0) and 12 months after treatment.
Figure 3  Gastric mucosa at the ulcer edge before and after
eradication of H. pylori infection in the same patient. A, biopsy
of the ulcer edge before H. pylori eradication showing antral-
type gastric mucosa with severe active chronic inflammation;
B, biopsy of the healed ulcer site after H. pylori eradication show-
ing body-type gastric mucosa with presence of parietal and
chief cells in the gastric glands and mild residual chronic
inflammation. Haematoxylin & eosin (H&E) staining ×250.
      Histological improvement of gastric mucosa was observed
in 14 (21.5 %) patients; 3 at the gastric body, 9 at the ulcer site
and 2 at both sites (Figure 3). Histological improvement of
gastric mucosa at the ulcer sites was more common in patients
in whom H. pylori was eradicated than those with persistent
infection (35.7 % vs 2.7 %, OR=20.0, 95 % CI: 2.37-168.6,
c2=12.35, P<0.001) (Table 2). When patients with relapsed
ulcers were excluded, the association remained unchanged
(37.0 % vs 3.8 %, OR=14.71, 95 % CI: 1.72-125.7, c2=8.87,
P=0.003). Similarly, triple therapy was associated with a higher
rate of histological improvement at the ulcer site, compared
to omeprazole treatment (31.0 % vs 5.6 %, OR=7.65, 95 %
CI: 1.50-39.0, c2=5.72, P=0.017). Gastric mucosa at the ulcer
site was improved in more patients with cured ulcers than those
Table 2  Changes of gastric mucosa at the edge of proximal gastric ulcers and gastric body one year after treatment, in relation to
post-treatment H. pylori status, treatment regimens, ulcer relapse and ulcer location (n=65)
Mucosal type change (%)
          Ulcer edge           Gastric body
Improvementa           No changeb Worseningc    Improvement No change   Worsening
      (n=11)                (n=49)      (n=5)           (n=5)    (n=58)        (n=2)
H. pylori infection
    Eradicated (n=28)        35.7d    64.3         0           14.3      85.7            0
    Persistent (n=37)          2.7    83.8      13.5             2.7      91.9           5.4
Ulcer location
    Incisura (n=52)        15.4    76.9        7.7             5.8      90.4           3.8
    Body (n=13)        23.1    69.2        7.7           15.4      84.6            0
a, Improvement, antral-type (A) transitional type (T), A body-type (B), or T B; b, No change, A A, T T or B B; c, Worsening,
T A, B A or B T. d, P<0.001, compared with persistent infection.
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with relapsed ulcers, although the difference did not reach
statistical significance (20.8 % vs 0 %, P=0.109). There was no
difference in histological improvement between patients with
ulcers at the body/fundus and those with ulcers at the incisura
(23.1 % vs 15.4 %, OR=1.65, 95 % CI: 0.37-7.35, P=0.804)
(Table 2). Age and gender were not associated with histological
improvement (data not shown).
     Overall, 7 (10.8 %) patients had worsened histology after
treatment; 5 at the ulcer edge and the other 2 at the gastric
body (Table 2). All of these patients had persistent H. pylori
infection; 6 were treated with omeprazole and one with triple
therapy. 3 (75 %) of these patients had ulcer relapsed.
DISCUSSION
In the present study, approximately 90 % of patients with
proximal gastric ulcers had antral-type mucosa at the ulcer
edge, and H. pylori infection was associated with a higher
prevalence of antralization in the proximal gastric ulceration.
Moreover, eradication of H. pylori infection resulted in
histological improvement at the ulcer edge of 36 % of patients
in 12 months, whereas the persistence of the infection was
accompanied by worsening of histology (14 %). These
findings suggest that H. pylori infection contributes to
antralization, which may, in turn, play an important role in
gastric ulceration.
    H. pylori-associated antralization is believed to be a
consequence of direct insults of chronic H. pylori infection, as
a host defense and reparative response to the mucosal damage
caused by organisms. As demonstrated in our previous study
and in the present study, H. pylori infection is associated with
antralization (or pseudopyloric metaplasia) at the gastric
incisura and less frequently at the body and fundus[18]. It has
been established that H. pylori infection induces apoptosis of
gastric epithelial cells, and subsequently stimulates cell
proliferation in the gastric mucosa[22]. Hanby et al reported
that mucous neck cells formed an important cell lineage which
secretes a series of peptides including the spasmolytic
polypeptide, or trefoil family factor 2 (TFF-2) with luminal
protective functions[23]. It has been suggested that pseudopyloric
metaplasia occurs in the body glands as a result of hyperplasia
of mucous neck cells, and represents a mucosal response to
damage associated with H. pylori infection[18, 23]. Indeed,
Schmidt et al reported that the spasmolytic polypeptide-
expressing metaplastic (SPEM) lineage was closely associated
with fundic H. pylori infection[24]. Thus, we propose that the
hyperplastic mucous neck cells move both upwards and
particularly downwards in the oxyntic tubule, replace the
specialized parietal and chief cells, and create a mucous cell
lineage. This process can occur focally, occupying a single
oxyntic tubule, groups of tubules, or on a fairly massive scale
with many tubules involved[25]. Eventually a mucous gland,
which resembles pyloric glands, is formed, and thus
antralization of proximal gastric mucosa follows. It is most
likely that the weakened antralized mucosa in the proximal
stomach is prone to be further damaged by H. pylori, resulting in
ulceration even in the presence of subnormal acid production[26]
Therefore, in the presence of persistent chronic infection with
H. pylori, this defense and reparative mechanism probably
facilitates rather than prevents the development of ulceration.
     In the present study, eradication of H. pylori infection led
to histological improvement, and persistent infection was
associated with the development of antralization in the proximal
stomach. These observations may have implications for the
prevention of the development of gastric cancer, as we have
previously reported that antralization of gastric incisura is
strongly associated with precancerous lesions such as gastric
atrophy and intestinal metaplasia[18]. It has been shown that
the time-dependent progression of gastritis in grade
(development of atrophy and intestinal metaplasia) and in
extent (spreading of gastritis by pyloro-cardial extension) is
correlated with the development of gastric cancer in the distal
and angular stomach[27], and that atrophic gastritis and intestinal
metaplasia progress and exhibit a cephaloid shift (i.e. pyloro-
cardial extension) in chronic H. pylori infection[28]. Therefore,
it is hypothesized that the initial events in gastric carcinogenesis
occur at the junction of the oxyntic and antral mucosae, and it
is the antral type mucosa that is prone to gastric atrophy and
intestinal metaplasia, and expansion of antral mucosa towards
the proximal stomach (either by pyloro-cardial extension or
by differentiation) may be associated with an increased risk of
developing intestinal metaplasia[29]. However, gastric atrophy
and intestinal metaplasia are unlikely to regress after eradication
of H. pylori infection although this is controversial[30-33]. On
the other hand, the reversibility of antralization at the proximal
gastric mucosa may provide a new hallmark in the
chemoprevention of gastric cancer, although further studies
on the role of antralization in gastric carcinogenesis are
required. If the proposals of Schmidt et al[24] are confirmed,
the prevention or reversal of SPEM might be critical.
   Sampling error might account for the difference in
improvement of gastric mucosa between patients with H. pylori
eradication and those with persistent infection. For example,
biopsies may be more correctly taken at the edge of active
ulcers than healed ulcers. In most cases, ulcer scars are visible,
which helps to improve the accuracy of the biopsy site.
     Notably, the rate of antralization reached 60 % (9/15) for
patients with proximal ulcers but without H. pylori infection,
suggesting that certain other factors that result in gastric
mucosal damage also lead to antralization and gastric
ulceration. In the present study, there were no documented
records on the causes of H. pylori-negative gastric ulcers, and
thus we were unable to identify the potential factors that may
lead to antralization. Some NSAID users who were unaware
of NSAID use at entry might have been included. Previously,
Lanas et al demonstrated that between 13 % and 22 % of
patients with gastrointestinal bleeding and perforation who
claimed not to have used aspirin had objective evidence of
current aspirin intake[34, 35]. If this were the case in the present
study, then NSAID use would account for proximal gastric
ulcer in up to 3 of the 15 patients. Nevertheless, the significance
of NSAID use and other factors in antralization of proximal
stomach remains to be clarified.
    In conclusion, H. pylori infection is associated with
antralization at the edge of proximal gastric ulcers, which may
be reversible in a proportion of patients after eradication of H.
pylori infection. Antralization in the proximal stomach may
play an important role in the pathogenesis of gastric ulceration.
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